SCHEMBL7763206

SCHEMBL7763206

CSCCC(CO)NC(=O)C(CCCc1ccc(-c2ccccc2)cc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MME P08473 3/20 0.41
ACE P12821 2/20 0.41
CPA1 P15085 2/20 0.41
ACE2 Q9BYF1 2/20 0.41
ANPEP P15144 1/20 0.40
LTA4H P09960 1/20 0.40
MGLL Q99685 1/20 0.40
MMP12 P39900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7761454 0.93 ANPEP (0.45) ANPEPLTA4H
SCHEMBL7762291 0.87 MMP2 (0.41) MMEACECPA1ACE2ANPEP
SCHEMBL7761493 0.74 FDFT1 (0.42) MMEMGLLMMP12
SCHEMBL6270672 0.70 MMP2 (0.65)
SCHEMBL6270662 0.70 MMP2 (0.65)
SCHEMBL15304889 0.70 MEN1 (0.54)
SCHEMBL11126931 0.70 MME (0.60) MME
SCHEMBL11128326 0.70 MME (0.60) MME
SCHEMBL7765152 0.70 MMP2 (0.55) MMP12
SCHEMBL7758522 0.70 MMP2 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098662-A2 COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS WARNER-LAMBERT COMPANY (US) 2001-05-16 EP claimed
WO-2000004892-A2 COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS WARNER-LAMBERT COMPANY (US) 2000-02-03 WO claimed